Literature DB >> 31104775

Adherence to Blood Cholesterol Treatment Guidelines Among Physicians Managing Patients With Atherosclerotic Cardiovascular Disease.

Eddison Ramsaran1, Peggy Preusse1, Devi Sundaresan1, Stefan DiMario2, Jeetvan Patel2, David Harrison2, Michael Munsell3, Joseph Menzin4.   

Abstract

The ACC/AHA blood cholesterol treatment guidelines recommend statin therapy for all patients after experiencing an acute cardiovascular event. Previous analyses have shown that physicians have been slow to adopt guidelines, and many patients remain untreated or undertreated with statins after a cardiovascular event. However, reasons for this remain unknown. This analysis used electronic medical records and patient chart data from Reliant Medical Group (Worcester, Massachusetts) to evaluate physician adherence to the 2013 ACC/AHA blood cholesterol guidelines when treating patients with evidence of acute atherosclerotic cardiovascular disease and the reasons for the observed treatment decisions. Less than 50% of acute atherosclerotic cardiovascular disease patients were treated according to the ACC/AHA guidelines. Nearly 42% of patients not treated according to guidelines received a lower statin intensity than recommended. The most common reason cited by 41.8% of physicians for treating with a statin intensity below the recommended intensity was low-density lipoprotein cholesterol stable or at goal, despite ACC/AHA guidelines recommending specific statin intensities rather than specific low-density lipoprotein cholesterol levels. In conclusion, physician and patient education on the importance of maximizing lipid-lowering therapy in this high-risk patient population should be emphasized.
Copyright © 2019 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31104775     DOI: 10.1016/j.amjcard.2019.04.017

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  7 in total

1.  Adherence to Current Lipid Guidelines by Physicians in Kuwait.

Authors:  Salwa Alhajji; Segun Mojiminiyi
Journal:  Med Princ Pract       Date:  2019-12-06       Impact factor: 1.927

2.  An exploratory survey on the awareness and usage of clinical practice guidelines among clinical pharmacists.

Authors:  Jessica M Downes; Lisa A Appeddu; Jeremy L Johnson; Kelsey S Haywood; B Jordan James; Kendrick D Wingard
Journal:  Explor Res Clin Soc Pharm       Date:  2021-04-21

3.  Low-density lipoprotein cholesterol lowering in real-world patients treated with evolocumab.

Authors:  Nihar R Desai; Rolin L Wade; Pin Xiang; Lionel Pinto; Sasikiran Nunna; Xin Wang; Jason Exter; Katherine E Mues; Mohdhar Habib; Chi-Chang Chen
Journal:  Clin Cardiol       Date:  2021-03-24       Impact factor: 2.882

4.  Effect of Pharmacogenetic Testing for Statin Myopathy Risk vs Usual Care on Blood Cholesterol: A Randomized Clinical Trial.

Authors:  Jason L Vassy; J Michael Gaziano; Robert C Green; Ryan E Ferguson; Sanjay Advani; Stephen J Miller; Sojeong Chun; Anthony K Hage; Soo-Ji Seo; Nilla Majahalme; Lauren MacMullen; Andrew J Zimolzak; Charles A Brunette
Journal:  JAMA Netw Open       Date:  2020-12-01

Review 5.  There is urgent need to treat atherosclerotic cardiovascular disease risk earlier, more intensively, and with greater precision: A review of current practice and recommendations for improved effectiveness.

Authors:  Michael E Makover; Michael D Shapiro; Peter P Toth
Journal:  Am J Prev Cardiol       Date:  2022-08-06

6.  Low-Density Lipoprotein Cholesterol Treatment Rates in High Risk Patients: More Disappointment Despite Ever More Refined Evidence-Based Guidelines.

Authors:  Peter P Toth
Journal:  Am J Prev Cardiol       Date:  2021-04-23

7.  Geographic variations in lipid-lowering therapy utilization, LDL-C levels, and proportion retrospectively meeting the ACC/AHA very high-risk criteria in a real-world population of patients with major atherosclerotic cardiovascular disease events in the United States.

Authors:  Seth J Baum; Pallavi B Rane; Sasikiran Nunna; Mohdhar Habib; Kiran Philip; Kainan Sun; Xin Wang; Rolin L Wade
Journal:  Am J Prev Cardiol       Date:  2021-03-30
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.